Neelima Kukreti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Neelima Kukreti has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Ahsas Goyal
Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India
2 shared publications - Asif Ahmad Bhat
School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, India
2 shared publications - Gaurav Gupta
Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Punjab, India
2 shared publications - Haider Ali
Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, India
2 shared publications - Imran Kazmi
Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia
2 shared publications - Kamal Dua
NICM Health Research Institute and School of Science, Western Sydney University, Westmead, Sydney, Australia
2 shared publications
Latest Publications
- Open Access
- 14 July 2026
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 25, 1117-1123
Corrigendum "Ferroptosis and circular RNAs: new horizons in cancer therapy"
EXCLI Journal - Experimental and Clinical Sciences, International Online Journal for Advances in Sciences
- 14 July 2026
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 25, 1117-1123
Open AccessCorrigendum "Ferroptosis and circular RNAs: new horizons in cancer therapy"
EXCLI Journal - Experimental and Clinical Sciences, International Online Journal for Advances in Sciences
- Open Access
- 25 April 2024
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 23, 570-599
Ferroptosis and circular RNAs
Cancer poses intricate challenges to treatment due to its complexity and diversity. Ferroptosis and circular RNAs (circRNAs) are emerging as innovative therapeutic avenues amid the evolving landscape of cancer therapy. Extensive investigations into circRNAs reveal their diverse roles, ranging from molecular regulators to pivotal influencers of ferroptosis in cancer cell lines. The results underscore the significance of circRNAs in modulating molecular pathways that impact crucial aspects of cancer development, including cell survival, proliferation, and metastasis. A detailed analysis delineates these pathways, shedding light on the molecular mechanisms through which circRNAs influence ferroptosis. Building upon recent experimental findings, the study evaluates the therapeutic potential of targeting circRNAs to induce ferroptosis. By identifying specific circRNAs associated with the etiology of cancer, this analysis paves the way for the development of targeted therapeutics that exploit vulnerabilities in cancer cells. This review consolidates the existing understanding of ferroptosis and circRNAs, emphasizing their role in cancer therapy and providing impetus for ongoing research in this dynamic field.
- 25 April 2024
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 23, 570-599
Open AccessFerroptosis and circular RNAs
Cancer poses intricate challenges to treatment due to its complexity and diversity. Ferroptosis and circular RNAs (circRNAs) are emerging as innovative therapeutic avenues amid the evolving landscape of cancer therapy. Extensive investigations into circRNAs reveal their diverse roles, ranging from molecular regulators to pivotal influencers of ferroptosis in cancer cell lines. The results underscore the significance of circRNAs in modulating molecular pathways that impact crucial aspects of cancer development, including cell survival, proliferation, and metastasis. A detailed analysis delineates these pathways, shedding light on the molecular mechanisms through which circRNAs influence ferroptosis. Building upon recent experimental findings, the study evaluates the therapeutic potential of targeting circRNAs to induce ferroptosis. By identifying specific circRNAs associated with the etiology of cancer, this analysis paves the way for the development of targeted therapeutics that exploit vulnerabilities in cancer cells. This review consolidates the existing understanding of ferroptosis and circRNAs, emphasizing their role in cancer therapy and providing impetus for ongoing research in this dynamic field.